We hypothesized that higher ERFE concentrations would be independently associated with lower hemoglobin levels and reduced eGFR, reflecting a maladaptive activation of the ERFE–hepcidin axis in progressive CKD. This evidence concerns the gene HAMP and chronic kidney disease.